News

Print

Product News and Articles

- of Articles PreviousPrevious Next Next

02-August-2017

Bio-Rad Launches Recombinant Luteinizing Hormone, Expanding its Critical Raw Materials Portfolio

Bio-Rad Launches Recombinant Luteinizing Hormone, Expanding its Critical Raw Materials Portfolio
More

28-July-2017

Bio-Rad Receives FDA Clearance to Aid in Diagnosing Diabetes with its <nobr>D-10</nobr> Hemoglobin A1c Program

Bio-Rad Receives FDA Clearance to Aid in Diagnosing Diabetes with its D-10 Hemoglobin A1c Program
More

25-July-2017

Bio-Rad Signs Agreement with VISIA Imaging for Fully-Automated IFA Slide Processing and Reading System

Bio-Rad Signs Agreement with VISIA Imaging for Fully-Automated IFA Slide Processing and Reading System
More

24-July-2017

Bio-Rad Announces the Addition of Analytes for Liquichek Tumor Marker Control

Bio-Rad Announces the Addition of Analytes for Liquichek Tumor Marker Control
More

05-July-2017

Bio-Rad Announces FDA Clearance of its BioPlex 2200 ToRC IgM Assay

The BioPlex 2200 ToRC IgM Assay is a fully automated assay for the detection of IgM class antibodies to <em>Toxoplasma gondii</em>, rubella, and cytomegalovirus (CMV) offered in a multiplexed panel.
More

22-May-2017

Technical Support Update

Microsoft operating systems recently experienced a security vulnerability resulting from a widespread ransomware attack through Microsoft’s network environments on a global scale. Bio-Rad’s internal IT team has evaluated the technical details of the Microsoft security update and has approved the patch.
More

25-January-2017

Bio-Rad Launches Amplichek STI

Bio-Rad Launches Amplichek STI, the Third in a Series of Quality Controls for the Molecular Diagnostics Testing Market
More

22-November-2016

Bio-Rad Announces CE Marking of its BioPlex 2200 Syphilis Total & RPR Assay, a Novel Syphilis Testing Method

Bio-Rad Laboratories, Inc. today announced CE IVD marking for its BioPlex 2200 Syphilis Total & RPR assay, a novel universal testing method to aid in the diagnosis of syphilis infection.
More

24-October-2016

Bio-Rad Introduces its IH-1000 Blood Typing System for the U.S. Market

Bio-Rad Laboratories, Inc. today announced that it has received clearance from the U.S. Food and Drug Administration (FDA) for its IH-1000 blood typing instrument along with approvals for a wide range of associated gel cards and reagents for the U.S. blood typing market.
More

03-August-2016

Amplichek I Quality Control

Bio-Rad Launches Amplichek I Quality Control, the Second in a Series of Controls for the Molecular Diagnostics Testing Market
More

06-June-2016

Liquichek&trade; Maternal Serum II Control

Bio-Rad Announces the Release of Liquichek&trade; Maternal Serum II Control. The Multi-Constituent Control Offers Increased Efficiency and Confidence in Test Results.
More

26-February-2016

Bio-Rad Announces CE IVD Marking of its QX200 Droplet Digital PCR System for Use as an In Vitro Diagnostic

Researchers can use the QX200 system for highly-accurate detection and quantification of nucleic acids, aiding clinical decision-making in the treatment of diseases ranging from cancer to transplant rejection and viral infection.
More

28-September-2015

Bio-Rad Unveils Critical Raw Material Antigens for Diagnostic Uses

Bio-Rad announced the launch of human recombinant protein antigens, which expand the company’s critical raw material offering.
More

06-August-2015

New Lyphochek® Allergen sIgE Controls

Bio-Rad Releases New Lyphochek® Allergen sIgE Controls to Monitor Precision of In Vitro Allergy Test Procedures. Offering Cost Savings, Increased Efficiencies, and Less Waste
More

16-June-2015

Important Information for Bio-Rad Customers in North America: Business Systems Update

Bio-Rad Laboratories will complete a business systems update on July 6. Impacts to business operations will be minimal, but North American customers should note that Bio-Rad will not ship products from July 1&ndash;July 5; shipping will resume on July 6. New customer account numbers and other changes to customer-facing data formats will also be implemented on this date.
More

09-May-2014

Bio-Rad celebrates the 1000th IH-1000 System Installation in the Field!

The IH-1000 system has revolutionized Immunohematology testing worldwide. After only four years since introduction and as a measure of its resounding success, we are delighted to announce the installation of the 1000th IH-1000 system!
More

22-January-2014

Bio-Rad Quality Controls Are Now Available in Dimension Vista Vials

Bio-Rad has announced a comprehensive line of multi-analyte quality controls now available in Siemens Dimension Vista&reg; vials for use on Siemens Dimension Vista&reg; Intelligent Lab Systems.
More

19-December-2013

Liquichek Maternal Serum 1st Trimester Control

Bio-Rad announces the launch of Liquichek Maternal Serum 1st Trimester Control
More

20-February-2013

Bio-Rad and Inpeco Announce Agreement to Connect Bio-Rad Diagnostic Platforms to Inpeco&rsquo;s Total Lab Automation System

Inpeco, a leading company in the field of laboratory automation, has entered into a development agreement to build interfaces between Bio-Rad’s clinical diagnostics platforms for diabetes, autoimmune disease, and infectious disease testing and Inpeco&rsquo;s FlexLab™ 3.6 system.
More

20-February-2013

Bio-Rad Laboratories Expands Their EQAS Offering with Three New Programs

Bio-Rad Laboratories announces the release of three External Quality Assurance Service (EQAS&reg;) Programs for clinical laboratories and near patient/POC settings around the world. The new programs are: Cardiac Markers, Ethanol/Ammonia, and Lipids.
More

20-February-2013

Bio-Rad Laboratories launches the EQAS Coagulation Program

Bio-Rad Laboratories announced the release of External Quality Assurance Service (EQAS) Coagulation Program for clinical laboratories around the world.
More

20-February-2013

Bio-Rad Laboratories launches the EQAS Blood Gas Program

Bio-Rad Laboratories announced the release of its External Quality Assurance Service (EQAS) Blood Gas Program
More

20-February-2013

Bio-Rad and Inpeco Announce Agreement to Connect Bio-Rad Diagnostic Platforms to Inpeco&rsquo;s Total Lab Automation System

Inpeco, a leading company in the field of laboratory automation, has entered into a development agreement to build interfaces between Bio-Rad’s clinical diagnostics platforms for diabetes, autoimmune disease, and infectious disease testing and Inpeco&rsquo;s FlexLab™ 3.6 system.
More

17-January-2013

Bio-Rad Introduces EQAS Mobile

Bio-Rad Introduces EQAS Mobile, an Easy Way for Clinical Labs to Submit Proficiency Testing Results Using a Smartphone
More

17-January-2013

Bio-Rad Introduces Liquichek Whole Blood Immunosuppressant Control

This third party, human whole blood based product is designed for use as an assayed quality control material to monitor the precision of immunosuppressant drug testing procedures in the clinical laboratory. Its liquid formulation is suitable for use with immunoassay and chromatographic techniques.
More

07-February-2012

Bio-Rad Launches My eInserts&trade;, the First Internet-Based Tool for Customizing QC Insert Data

Bio-Rad announces My eInserts&trade;, a free Internet-based tool that will allow Bio-Rad’s quality control (QC) customers to customize and view their product inserts at any time. My eInserts offers Bio-Rad's QC customers the option to customize their QC product insert data by selecting only the analytes, units, instruments, and/or methods they need.
More

13-December-2011

Siemens and Bio-Rad Extend Joint Marketing Agreement for IMMULITE and Dimension Systems to Further Optimize Efficiency and Data Reliability

Agreement extends clinical laboratories’ access to Bio-Rad’s consistent control product and data management tools within the Siemens clinical laboratory systems portfolio which, until today, were only available through Siemens’ ADVIA<sup>&reg;</sup> Chemistry and ADVIA Centaur<sup>&reg;</sup> Immunoassay systems.
More

13-October-2010

Bio-Rad and Axis-Shield Announce FDA Clearance and U.S. Launch of an Anti-CCP Test for Rheumatoid Arthritis for Bio-Rad's BioPlex 2200 System

The assay, which runs on Bio-Rad's BioPlex<sup>&reg;</sup> 2200 system, measures anti-CCP, a novel marker that has been shown to have superior specificity in the diagnosis of rheumatoid arthritis.
More

30-June-2010

Bio-Rad Introduces its IH 1000, an Automated Blood Screening System

The IH 1000 is a fully-automated, high-throughput system designed for the blood transfusion laboratory utilizing the industry accepted gold standard ID-System gel card technology.
More

24-May-2010

Bio-Rad Launches a Measles, Mumps, Rubella, and Varicella-Zoster Virus IgG Kit for its BioPlex 2200 System

With the introduction of the BioPlex 2200 MMRV IgG kit, Bio-Rad offers a compelling menu for infectious disease serology and autoimmune testing laboratories.
More

19-April-2010

Liquichek Opiate Control

BIO-RAD Introduces Liquichek Opiate Control.
More

30-March-2010

Liquichek Hematology and Reticulocyte Controls (X)

BIO-RAD Introduces Liquichek Hematology and Reticulocyte Controls for Sysmex Hematology Instruments.
More

08-March-2010

Liquichek Hematology and Reticulocyte Controls (A-I)

BIO-RAD Introduces Liquichek Hematology and Reticulocyte Controls for Abbott CELL-DYN Sapphire and CELL-DYN 4000 Instruments
More

05-March-2010

Liquichek Hematology and Reticulocyte Controls (S)

BIO-RAD Introduces Liquichek Hematology and Reticulocyte Controls for Siemens ADVIA Instruments.
More

06-January-2010

Bio-Rad Completes the Purchase of Certain Diagnostics Businesses of Biotest AG

Bio-Rad is pleased to expand its product offering in the area of immunohematology through the purchase of certain diagnostics businesses of Biotest AG.
More

15-July-2008

MRSA<em>Select</em> - Rapid Screening of MRSA

Bio-Rad's chromogenic test for rapid screening of MRSA now offers faster interpretation time.
More

11-February-2008

BioPlex 2200 Streamlines Vasculitis Testing

Novel automated multiplexing technology streamlines vasculitis testing, maximizes efficiency.
More

18-January-2008

Lyphochek Whole Blood Immunosuppressant Control

Bio-Rad announces the release of Lyphochek Whole Blood Immunosuppressant Control.
More

15-January-2008

Liquichek Microalbumin Control

Bio-Rad announces the launch of Liquichek Microalbumin Control for microalbumin testing.
More

07-January-2008

Candi<em>Select</em> 4 Identifies Four Candida Species

Bio-Rad introduces a second chromogenic medium in the US for identification of four Candida species.
More

17-December-2007

Liquichek Diabetes Control

Bio-Rad announces the launch of Liquichek Diabetes Control for monitoring Hemoglobin A1C tests.
More

Sign Up for Bio-Rad Updates!
Enter your email address below to receive your choice of the latest news, promotions, and more.
Get Help